WNCT

FDA Grants Priority Review for Addyi® (flibanserin) Paving the Way for Expanded Access to Treat Low Sexual Desire in Postmenopausal Women

Addyi is the first and only FDA-approved, hormone-free pill clinically proven to treat low sexual desire in women RALEIGH, N.C., July 24, 2025 /PRNewswire/ -- Sprout Pharmaceuticals today announced ...
Yahoo

Meet the Addyi Pill—a.k.a. Pink Viagra: Why the FDA's New 2025 Approval Is a ‘Historic First’ for Women Over 50

Add Yahoo as a preferred source to see more of our stories on Google. Viagra, the little blue pill, has been a household name for more than a generation. And now women’s sexual health is finally ...
KRQE Blogs

Unprecedented Abstract Highlights Addyi’s Remarkable Effects on Low Libido among Breast Cancer Patients

IRVINE, CA – July 5, 2023 – The Ad Firm is thrilled to announce the publication of an abstract by Sprout Pharmaceuticals, showcasing the remarkable effects of Addyi (flibanserin) on low libido among ...

The battle to get ‘female Viagra’ to market — and how ‘Grey’s Anatomy’ played a role

Sex, Drugs & Who Has Control” — premiering Friday on Paramount+ — explores the obstacles that Addyi overcame to securing FDA ...
Opinion

The Pink Pill: New documentary exposes the long battle to bring Addyi — the first libido drug for women — to market

Ever wonder why there are 26 medications for male sexual disorders and only one drug for women who experience low libido? Perhaps it’s because this glaring example of medical sexism has not been ...
WAPT

FDA OKs libido-boosting pill for older women who have gone through menopause

U.S. health officials have expanded approval of a much-debated drug aimed at boosting female libido, saying the once-a-day pill can now be taken by postmenopausal women up to 65 years old.The ...